Cargando…
In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease
BACKGROUND: Lyme disease accounts for >90% of all vector-borne disease cases in the United States and affect ~300,000 persons annually in North America. Though traditional tetracycline antibiotic therapy is generally prescribed for Lyme disease, still 10%–20% of patients treated with current anti...
Autores principales: | Pothineni, Venkata Raveendra, Parekh, Mansi B, Babar, Mustafeez Mujtaba, Ambati, Aditya, Maguire, Peter, Inayathullah, Mohammed, Kim, Kwang-Min, Tayebi, Lobat, Potula, Hari-Hara SK, Rajadas, Jayakumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141111/ https://www.ncbi.nlm.nih.gov/pubmed/30254421 http://dx.doi.org/10.2147/DDDT.S164966 |
Ejemplares similares
-
Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening
por: Pothineni, Venkata Raveendra, et al.
Publicado: (2016) -
Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31
por: Pothineni, Venkata Raveendra, et al.
Publicado: (2020) -
Borreliacidal activity of Borrelia metal transporter A (BmtA) binding small molecules by manganese transport inhibition
por: Wagh, Dhananjay, et al.
Publicado: (2015) -
Repurposing Disulfiram (Tetraethylthiuram Disulfide) as a Potential Drug Candidate against Borrelia burgdorferi In Vitro and In Vivo
por: Potula, Hari-Hara S. K., et al.
Publicado: (2020) -
Effect of osmolytes on the conformation and aggregation of some amyloid peptides: CD spectroscopic data
por: Inayathullah, Mohammed, et al.
Publicado: (2016)